New hope for tough gout cases: trial tests Next-Line treatment
Disease control
Recruiting now
This study is testing a new combination of medications (AR882 with a standard drug) for people with severe, uncontrolled gout. It's specifically for those whose gout did not improve or who had bad reactions to a previous strong treatment called uricase. The main goals are to see …
Phase: PHASE2 • Sponsor: Arthrosi Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC